You are here: Home - Investing - Experienced Investor - News -

Stock of the week: Hikma Pharmaceuticals

Written by:
Graham Spooner, investment research analyst at The Share Centre, explains why he’s picked Hikma as stock of the week.

This week’s stock of the week is international pharmaceutical company Hikma Pharmaceuticals which has recently impressed the market with raised forecasts for 2018.

Hikma is set apart from its larger pharmaceutical rivals in that its focus on both branded and unbranded generic drugs and its sales exposure is geared towards the Middle Eastern, North African and American markets.

The group was founded in Jordan in the late seventies and subsequently grew due to demand for affordable drugs and the needs of a growing population in the region. The trend that generic drugs will continue to take an increasing share of the market is becoming more apparent and Hikma is in a good position to benefit from this.

In regards to products, the group holds a strong pipeline which are currently seeking FDA approval and despite the setback in the launch of a generic version of Glaxo’s Advair Diskus (asthma) product, management remain confident of addressing the US regulators demands, with new data expected in 2019.

Interim results in August gave the share price a boost with earnings at the top end of expectations. Profit rose by 41% to $141m on the back of an 11% rise in revenue to $989m. The dividend was 12 cents (11c). The important injectables business performed well in the US. The company raised its guidance for the year for its generics and injectables divisions.

The company hope to be well positioned from the many drivers of growth in this sector and to take full advantage it continues to place emphasis on its pipeline. Improved results this year has seen a sharp rebound in the share price to a 15-month high, following on from a difficult 2017.

However, we continue with our ‘buy’ recommendation for investors seeking capital growth and willing to accept a higher level of risk.

There are 0 Comment(s)

If you wish to comment without signing in, click your cursor in the top box and tick the 'Sign in as a guest' box at the bottom.

Everything you wanted to know about ISAs…but were afraid to ask

The new tax year is less than a fortnight away and for ISA savers or investors, it’s hugely important. If yo...

Your right to a refund if travel is affected by train strikes

There have been a wave of train strikes in the past six months, and for anyone travelling today Friday 3 Febru...

Could you save money with a social broadband tariff?

Two-thirds of low-income households are unaware they could be saving on broadband, according to Uswitch.

What will happen if rates change

How your finances will be impacted by a rise in interest rates.

Regular Savings Calculator

Small regular contributions can build up nicely over time.

Online Savings Calculator

Work out how your online savings can build over time.

DIY investors: 10 common mistakes to avoid

For those without the help and experience of an adviser, here are 10 common DIY investor mistakes to avoid.

Mortgage down-valuations: Tips to avoid pulling out of a house sale

Down-valuations are on the rise. So, what does it mean for home buyers, and what can you do?

Five tips for surviving a bear market mauling

The S&P 500 has slipped into bear market territory and for UK investors, the FTSE 250 is also on the edge. Her...

Money Tips of the Week